Amerikanische Gesellschaft für Hirudotherapie

The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda)

Comparative transcriptomics published in BMC Genomics (2015)

Zuletzt aktualisiert: 18. Juni 2026Geprüft von: ASH Editorial Board
Forschungsartikel — EvidenzübersichtArtikelreferenz
Evidenz: Präklinisch (tierexperimentell)Genomik & ProteomikSpeichel-PharmakologieModica MV et al. · BMC genomics, 2015

Abstract

BACKGROUND: Hematophagy arose independently multiple times during metazoan evolution, with several lineages of vampire animals particularly diversified in invertebrates. However, the biochemistry of hematophagy has been studied in a few species of direct medical interest and is still underdeveloped in most invertebrates, as in general is the study of venom toxins. In cone snails, leeches, arthropods and snakes, the strong target specificity of venom toxins uniquely aligns them to industrial and academic pursuits (pharmacological applications, pest control etc.) and provides a biochemical tool for studying biological activities including cell signalling and immunological response. Neogastropod snails (cones, oyster drills etc.) are carnivorous and include active predators, scavengers, grazers on sessile invertebrates and hematophagous parasites; most of them use venoms to efficiently feed. It has been hypothesized that trophic innovations were the main drivers of rapid radiation of Neogastropoda in the late Cretaceous. We present here the first molecular characterization of the alimentary secretion of a non-conoidean neogastropod, Colubraria reticulata. Colubrariids successfully feed on the blood of fishes, throughout the secretion into the host of a complex mixture of anaesthetics and anticoagulants. We used a NGS RNA-Seq approach, integrated with differential expression analyses and custom searches for putative secreted feeding-related proteins, to describe in detail the salivary and mid-oesophageal transcriptomes of this Mediterranean vampire snail, with functional and evolutionary insights on major families of bioactive molecules. RESULTS: A remarkably low level of overlap was observed between the gene expression in the two target tissues, which also contained a high percentage of putatively secreted proteins when compared to the whole body. At least 12 families of feeding-related proteins were identified, including: 1) anaesthetics, such as ShK Toxin-containing proteins and turripeptides (ion-channel blockers), Cysteine-rich secretory proteins (CRISPs), Adenosine Deaminase (ADA); 2) inhibitors of primary haemostasis, such as novel vWFA domain-containing proteins, the Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (ENPP5) and the wasp Antigen-5; 3) anticoagulants, such as TFPI-like multiple Kunitz-type protease inhibitors, Peptidases S1 (PS1), CAP/ShKT domain-containing proteins, Astacin metalloproteases and Astacin/ShKT domain-containing proteins; 4) additional proteins, such the Angiotensin-Converting Enzyme (ACE: vasopressive) and the cytolytic Porins. CONCLUSIONS: Colubraria feeding physiology seems to involve inhibitors of both primary and secondary haemostasis, anaesthetics, a vasoconstrictive enzyme to reduce feeding time and tissue-degrading proteins such as Porins and Astacins. The complexity of Colubraria venomous cocktail and the divergence from the arsenal of the few neogastropods studied to date (mostly conoideans) suggest that biochemical diversification of neogastropods might be largely underestimated and worth of extensive investigation.

Abstract aus PubMed (NCBI) für den zitierten Eintrag, in der Originalsprache wiedergegeben. Maßgeblich ist die Fassung der Originalpublikation.

Das Abstract wird nicht übersetzt, damit die eigene Wortwahl der Autoren erhalten bleibt.

PublikationstypJournal ArticleResearch Support, Non-U.S. Gov't
Indexierte MeSH-BegriffeAnimalsDatabases, GeneticEsophagusGastropodaGene Expression ProfilingMollusk VenomsOrgan SpecificitySalivary GlandsSequence Analysis, RNA

Zusammenfassung

RNA-Seq of the salivary and mid-esophageal transcriptomes of the vampire snail Colubraria reticulata identified at least 12 families of secreted feeding-related proteins, including anaesthetics, anticoagulants such as Kunitz-type inhibitors, and inhibitors of primary haemostasis.

Kontext

Diese Studie nutzte RNA-Seq-Transkriptomik, um die Speichel- und mittleren Ösophagus-Sekrete der Vampirschncke Colubraria reticulata zu charakterisieren, und identifizierte mindestens 12 Familien nahrungsbezogener Proteine, darunter Anästhetika, Inhibitoren der primären Hämostase, Antikoagulanzien und gewebeabbauende Enzyme. Die Schnecke ernährt sich von Fischblut, indem sie einen komplexen Cocktail in den Wirt sezerniert. Diese Arbeit behandelt einen Gastropoden-Mollusken, und der Abstract erwähnt Blutegel nur als vergleichendes Beispiel für blutsaugende Wirbellose, deren Gifttoxine pharmakologische Relevanz besitzen.

Zitation

Literaturangabe (Vancouver-Stil)

Modica MV, Lombardo F, Franchini P, Oliverio M. The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda). BMC Genomics. 2015;16(1):441. doi:10.1186/s12864-015-1648-4. PMID: 26054852

Die bibliografischen Angaben (Autoren, Band, Seiten, DOI) stammen aus dem PubMed-Eintrag.

Verwandter klinischer Kontext

Verwandte Forschungsarbeiten

Weitere begutachtete Studien in der Kategorie „Genomik & Proteomik“.

Alle von der ASH analysierten Studien →

Zur ASH-Bibliothek hinzugefügt: 26. Mai 2026 · Letzte Aktualisierung der Website: 18. Juni 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Freigabe für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.